QT
ADMS

Quantbot Technologies’s Adamas Pharmaceuticals ADMS Stock Holding History

Quantbot Technologies’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,543
Closed -$21K – 2038
2021
Q1 		$21K Buy
+4,543
New +$23.7K ﹤0.01% 1171
2018
Q4 		– Sell
-2,617
Closed -$52K – 1559
2018
Q3 		$52K Buy
2,617
+1,354
+107% +$31.8K ﹤0.01% 1040
2018
Q2 		$32K Buy
+1,263
New +$35K ﹤0.01% 1042
2018
Q1 		– Sell
-2,634
Closed -$89K – 1611
2017
Q4 		$89K Sell
2,634
-3,013
-53% -$84.1K 0.01% 868
2017
Q3 		$119K Buy
+5,647
New +$104K 0.01% 809
2016
Q2 		– Sell
-649
Closed -$9K – 1460
2016
Q1 		$9K Sell
649
-2,604
-80% -$43.9K ﹤0.01% 1058
2015
Q4 		$92K Buy
+3,253
New +$54.8K 0.02% 674

Other funds holding ADMS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CCPM
Cooper Creek Partners Management New York $2.92B AUM 30.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Quantbot Technologies's ADMS Position: Q2 2021 in Review

Quantbot Technologies sold out of Adamas Pharmaceuticals (ADMS) in Q2 2021, closing a stake of 4,543 shares — an estimated $21K sold.

Quantbot Technologies first reported a position in ADMS in Q4 2015 and held it in 7 quarters. The position peaked at $119K in Q3 2017. 67 funds tracked by Wall St. Rank hold ADMS as of Q2 2021.

  • Quantbot Technologies reported no remaining Adamas Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantbot Technologies sold 4,543 Adamas Pharmaceuticals shares in Q2 2021, an estimated $21K.
  • Quantbot Technologies first reported a position in Adamas Pharmaceuticals in Q4 2015 and held it in 7 quarters.
  • Quantbot Technologies's Adamas Pharmaceuticals position peaked at $119K in Q3 2017.
  • 67 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2021.

Based on Quantbot Technologies's 13F filing for Q2 2021, filed 12 Aug 2021.